Selumetinib Sales Market Poised for Strong Growth Amid Rising Demand for Targeted Cancer Therapies Read More => https://dataintelo.com/report/global-selumetinib-sales-market The Selumetinib Sales Market is witnessing robust expansion as advancements in oncology and increased focus on precision medicine drive demand for MEK inhibitors. Selumetinib, a selective inhibitor of the mitogen-activated protein kinase (MAPK) pathway, is playing an increasingly vital role in the treatment of various cancers, especially neurofibromatosis type 1 (NF1) and certain thyroid cancers.